who discovered glp-1 The Discovery of Glucagon-Like Peptide 1 (GLP-1) | Global Health | JN Learning If you have something you

This is why these injectables are administered just before eating

Regular Check-ups: Regular visits to your healthcare provider will allow them to monitor any potential side effects and make adjustments to your treatment plan if necessary

The other three DPP-4 inhibitors, teneligliptin, anagliptin and trelagliptin, are only approved in the Japanese and Korean markets

Follow-up: What does follow-up care look like

Possible side effects include mild digestive changes (gas, bloating, or altered bowel habits) as your gut adjusts to the polyphenol content

Timing Most importantly, Novo Nordisk could beat its rival to the market